Literature DB >> 18556387

Vitamin K status of Canadian peritoneal dialysis patients.

Rachel M Holden1, Eduard Iliescu, A Ross Morton, Sarah L Booth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18556387

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  16 in total

1.  Menaquinone-4 modulates the expression levels of calcification-associated factors to inhibit calcification of rat aortic vascular smooth muscle cells in a dose-dependent manner.

Authors:  Liwen Cui; Jinsheng Xu; Junxia Zhang; Muqing Zhang; Shenglei Zhang; Yaling Bai
Journal:  Exp Ther Med       Date:  2018-07-27       Impact factor: 2.447

Review 2.  Vitamin K in CKD Bone Disorders.

Authors:  M Fusaro; G Cianciolo; P Evenepoel; L Schurgers; M Plebani
Journal:  Calcif Tissue Int       Date:  2021-01-06       Impact factor: 4.333

Review 3.  Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

Authors:  Maria Fusaro; Maurizio Gallieni; Camillo Porta; Thomas L Nickolas; Pascale Khairallah
Journal:  J Nephrol       Date:  2019-12-19       Impact factor: 3.902

Review 4.  Recent progress in the treatment of vascular calcification.

Authors:  W Charles O'Neill; Koba A Lomashvili
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 5.  Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Authors:  M Kyla Shea; Rachel M Holden
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

6.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

7.  Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

Authors:  Benjamin K A Thomson; Jennifer M MacRae; Lianne Barnieh; Jianguo Zhang; Elizabeth MacKay; Megan A Manning; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2011-09-26       Impact factor: 2.388

8.  Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.

Authors:  Rachel M Holden; Sarah L Booth; Andrew G Day; Catherine M Clase; Deborah Zimmerman; Louise Moist; M Kyla Shea; Kristin M McCabe; Sophie A Jamal; Sheldon Tobe; Jordan Weinstein; Rao Madhumathi; Michael A Adams; Daren K Heyland
Journal:  Can J Kidney Health Dis       Date:  2015-05-01

9.  Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.

Authors:  Meghan J Elliott; Sarah L Booth; Wilma M Hopman; Rachel M Holden
Journal:  Can J Kidney Health Dis       Date:  2014-06-24

Review 10.  Vitamin K status in chronic kidney disease.

Authors:  Kristin M McCabe; Michael A Adams; Rachel M Holden
Journal:  Nutrients       Date:  2013-11-07       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.